These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8932444)

  • 1. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist.
    Chang BS; Reeder G; Carpenter JF
    Pharm Res; 1996 Feb; 13(2):243-9. PubMed ID: 8932444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
    Chang BS; Beauvais RM; Dong A; Carpenter JF
    Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of formulation variables on the stability of freeze-dried human growth hormone.
    Pikal MJ; Dellerman KM; Roy ML; Riggin RM
    Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations.
    Roy S; Jung R; Kerwin BA; Randolph TW; Carpenter JF
    J Pharm Sci; 2005 Feb; 94(2):382-96. PubMed ID: 15614819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation.
    Bayol A; Breul T; Dupin P; Menegotto J; Aleman C; Duplaa H; Faure P; Bonnet MC; Bauer M
    Drug Dev Ind Pharm; 2004 Sep; 30(8):877-89. PubMed ID: 15521333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ.
    Osterberg T; Fatouros A; Mikaelsson M
    Pharm Res; 1997 Jul; 14(7):892-8. PubMed ID: 9244146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations.
    Page C; Dawson P; Woollacott D; Thorpe R; Mire-Sluis A
    J Pharm Pharmacol; 2000 Jan; 52(1):19-26. PubMed ID: 10716599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying.
    Santana H; Sotolongo J; González Y; Hernández G; Chinea G; Gerónimo H; Amarantes O; Beldarraín A; Páez R
    Biologicals; 2014 Nov; 42(6):322-33. PubMed ID: 25190208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
    Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
    Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of freeze-dried biosynthetic Factor VIII: I. A case study in the optimization of formulation.
    Jameel F; Tchessalov S; Bjornson E; Lu X; Besman M; Pikal M
    Pharm Dev Technol; 2009; 14(6):687-97. PubMed ID: 19883259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of formulation and moisture on the stability of a freeze-dried monoclonal antibody-vinca conjugate: a test of the WLF glass transition theory.
    Roy ML; Pikal MJ; Rickard EC; Maloney AM
    Dev Biol Stand; 1992; 74():323-39; discussion 340. PubMed ID: 1592182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
    Lueckel B; Helk B; Bodmer D; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
    Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
    PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallizing amino acids as bulking agents in freeze-drying.
    Horn J; Tolardo E; Fissore D; Friess W
    Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid.
    Kreilgaard L; Frokjaer S; Flink JM; Randolph TW; Carpenter JF
    J Pharm Sci; 1999 Mar; 88(3):281-90. PubMed ID: 10052984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.